Paper41683751
A Proteomic Study of the Dual Oncogenic and Tumor-Suppressive Roles of SIRT3 in Lung and Breast Cancer Cell Lines.
Ayala Reyes M and 5 others. Int J Mol Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A Proteomic Study of the Dual Oncogenic and Tumor-Suppressive Roles of SIRT3 in Lung and Breast Cancer Cell Lines. Papers, record 41683751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41683751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Proteomic Study of the Dual Oncogenic and Tumor-Suppressive Roles of SIRT3 in Lung and Breast Cancer Cell Lines.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirtuin 3 | Major topic |
| Lung Neoplasms | Major topic |
| Proteomics | Major topic |
| Breast Neoplasms | Major topic |
| Proteome | Major topic |
| Humans | |
| Female | |
| Acetylation | |
| MCF-7 Cells | |
| Mitochondria | |
| Metabolic Reprogramming | |
| Cell Line, Tumor | |
| A549 Cells | |
| Mitochondrial Proteins | |
| Protein Processing, Post-Translational |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IN-213522 and IN216626 | Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT-UNAM) | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29493120 | Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. | Cancer Med | 2018 | https://conductscience.org/library/papers/29493120 | PubMed |
| 2 | 24503539 | Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. | Cell Death Dis | 2014 | https://conductscience.org/library/papers/24503539 | PubMed |
| 3 | 30895811 | Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer. | Biomark Med | 2019 | https://conductscience.org/library/papers/30895811 | PubMed |
| 4 | 25449783 | Hypoxia-induced IL-32β increases glycolysis in breast cancer cells. | Cancer Lett | 2015 | https://conductscience.org/library/papers/25449783 | PubMed |
| 5 | 35327392 | Functional Enrichment Analysis of Regulatory Elements. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327392 | PubMed |
| 6 | 25811481 | SIRT3 and SIRT5 regulate the enzyme activity and cardiolipin binding of very long-chain acyl-CoA dehydrogenase. | PLoS One | 2015 | https://conductscience.org/library/papers/25811481 | PubMed |
| 7 | 32244715 | Sirt3 Exerts Its Tumor-Suppressive Role by Increasing p53 and Attenuating Response to Estrogen in MCF-7 Cells. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/32244715 | PubMed |
| 8 | 31204277 | A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis. | EBioMedicine | 2019 | https://conductscience.org/library/papers/31204277 | PubMed |
| 9 | 35832196 | The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy. | Front Genet | 2022 | https://conductscience.org/library/papers/35832196 | PubMed |
| 10 | 28711502 | A small molecule activator of SIRT3 promotes deacetylation and activation of manganese superoxide dismutase. | Free Radic Biol Med | 2017 | https://conductscience.org/library/papers/28711502 | PubMed |
| 11 | 35618735 | Homophilic ATP1A1 binding induces activin A secretion to promote EMT of tumor cells and myofibroblast activation. | Nat Commun | 2022 | https://conductscience.org/library/papers/35618735 | PubMed |
| 12 | 31564558 | Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. | Mol Cell | 2019 | https://conductscience.org/library/papers/31564558 | PubMed |
| 13 | 24486017 | Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. | Mol Cell | 2014 | https://conductscience.org/library/papers/24486017 | PubMed |
| 14 | 32898647 | Advances in characterization of SIRT3 deacetylation targets in mitochondrial function. | Biochimie | 2020 | https://conductscience.org/library/papers/32898647 | PubMed |
| 15 | 16790548 | Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16790548 | PubMed |
| 16 | 32165320 | APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis. | Semin Cancer Biol | 2020 | https://conductscience.org/library/papers/32165320 | PubMed |
| 17 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 18 | 34405009 | Sirt3 Promoted DNA Damage Repair and Radioresistance Through ATM-Chk2 in Non-small Cell Lung Cancer Cells. | J Cancer | 2021 | https://conductscience.org/library/papers/34405009 | PubMed |
| 19 | 27746255 | Lysine acetylation and cancer: A proteomics perspective. | J Proteomics | 2017 | https://conductscience.org/library/papers/27746255 | PubMed |
| 20 | 31750240 | Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma. | Front Oncol | 2019 | https://conductscience.org/library/papers/31750240 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42939938 | Adaptive Mitochondrial Specialization in Lung Adenocarcinoma: Redox Homeostasis, Hypoxia Adaptation, and Therapeutic Resistance. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939938 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SIRT3 | 23410 | PubTator's text mining | https://conductscience.org/library/genes/23410 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41683751
GET https://conductscience.org/api/papers/v1/41683751/references?page=2